The French Pavilion at #BIO2018 International Convention was a success!
Thanks to Ambassador Gerard Araud’s visit, the French Pavilion made history!
France was actually the 2nd largest presence at the International Convention.
France is back!
From June 3rd to June 7, 2018, it was all about France at #BIO2018 here in Boston!
It started with the Boston Paris Biotechnology Summit organized by Shahin and Soheila Gharakhanian with the support of Blend of Concept LLC. It was a full day of conferences covering questions a French biotech startup coming to Boston may have from the promise of raising capital to the reality of clinical trials.
On Sunday evening, IPSEN CEO David Meek offered a large reception to welcome Business France and all French delegations in Boston.
On Monday, Business France organized three panels showcasing France’s attractiveness and advanced competence in heathcare and biotech.
1st panel was about Artificial Intelligence in Healthcare: How to find the perfect balance between efficiency & ethics?
From left to right: Daniel Sarfaty, CEO at Aptima - Alexis Normand, Head of Business at Withings - Erik Thomsen, CTO at Blender Logic - Dr. Monica Lopez, Executive Director at La Petite Noiseuse Productions - Alexandre Blanchot, Healthcare Trade Advisor at Business France.
2nd panel was about France, an Economic Hub in Europe for Biotechnology.
From left to right: Emmanuel Dulac, CCO at Alnylam Pharmaceuticals - Isabelle Marguet, M&A Partner at Cabinet Dechert LLP - John Brennan, Secretary General at EuropaBio - Eric Forest, CEO of EnterNext at Euronext - Thomas Delano, Principal at BCG - Frederic Rossi, Business France - Maryvonne Hiance, President at France Biotech.
3rd panel discussed Emerging diseases, Pasteur’s legacy under the spotlight of Climate Change.
From left to right: Dr. Corley, Director at NEIDL - Benoit Gamain, Head of the Malaria Pathogenesis at INSERM - Dr. Gary Nabel, Chief Scientific Officer at Sanofi - Branka Horvat, Head of Immunobiology of Viral Infections at CIRI Lyon - Stéphane Bancel, CEO at Moderna.
Ambassador Gérard Araud joined forces to support all French delegations which came to Boston that week. On Tuesday morning, he officially opened the French Pavilion at the BIO International Convention.
Were with him at the grand opening, from left to right: Valery Freland, Consul General of France in Boston - Henri Baissas, Business France - John Barros, Chief of Economic Development for the City of Boston - His Excellency Ambassador Gérard Araud - Fousiya Bouzerda, VP Economic Development for Lyon - Karine Dognin-Sauze, Deputy-Mayor of Lyon in charge of International Relations - Frederic Rossi, Business France.
As part of BIO’s Global Leadership Forum, Ambassador Araud participated to a panel discussion asking the interesting question: Can Boston’s DNA be replicated globally?
The panel was moderated by Meir Pugatch, Chair of the Health Systems Administration Division at University of Haifa.
From left to right: Mmamoloko Kubayi-Ngubane, Minister of Science and Technology of South Africa - Gérard Araud, Ambassador of France to the US - Gintaras Vilda, Vice Minister of Economy of Lithuania - Herb Riband, International Policy and Government Affairs VP at Amgen - John Harthone, Founder & CEO at MassChallenge.
Ambassador Araud also visited some of the French companies established in the Boston area.
At Sanofi-Genzyme new headquarters, with CEO Bill Sibold:
At BIO Mérieux new headquarters, with François Valencony, General Manager of Mérieux Développement and President of MxD North America LLC:
Ambassador Gérard Araud also took the time to show his undefeated support to French startups and French regions, cities, clusters and universities which exhibited at the BIO International Conference 2018 in Boston.
Enjoy a few pictures of France’s incredible presence at #BIO2018!
